CoChat
Cited by 107

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments

Open access
Van den Berghe, Greet · 2016 · American Journal of Respiratory and Critical Care Medicine

Abstract

Typical for critical illnesses are substantial alterations within the hypothalamic-anterior pituitary-peripheral hormonal axes that are proportionate to the risk of poor outcome. These neuroendocrine responses to critical illness follow a biphasic pattern. The acute phase (first hours to days) is characterized by an increased release of anterior pituitary hormones, whereas altered target-organ sensitivity and hormone metabolism result in low levels of the anabolic peripheral effector hormones and contribute to the substantially elevated levels of the catabolic hormone cortisol. The prolonged phase of critical illness is hallmarked by a uniform suppression of the neuroendocrine axes, predominantly of central/hypothalamic origin, which contributes to the low (or insufficiently high in the case of cortisol) circulating levels of the target-organ hormones. Several of the acute-phase adaptations to critical illness are due to or accentuated by the concomitant fasting. Accepting the lack of macronutrients as well as the neuroendocrine responses to such fasting in the acute phase of critical illness has shown to beneficially affect outcome. In contrast, the neuroendocrine alterations that occur in the chronic phase of illness while patients are fully fed contribute to bone and skeletal muscle wasting and impose risk of adrenocortical atrophy. The combined administration of those hypothalamic releasing factors, which have been identified as suppressed or deficient during prolonged critical illness, may be a promising strategy to enhance recovery. The potential impact of treatment with such hypothalamic releasing factors on recovery from critical illness as well as on long-term rehabilitation should be investigated in future randomized controlled clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201607-1516ci

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 62

  1. Van den Berghe, 1998, Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms, J Clin Endocrinol Metab, 83, 1827
  2. Thorner, 1998, The anterior pituitary, 249
  3. Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 · DOI · Paper page
  4. Cowley, 2003, The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis, Neuron, 37, 649, 10.1016/S0896-6273(03)00063-1 · DOI · Paper page
  5. Bowers, 1984, On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone, Endocrinology, 114, 1537, 10.1210/endo-114-5-1537 · DOI · Paper page
  6. Howard, 1996, A receptor in pituitary and hypothalamus that functions in growth hormone release, Science, 273, 974, 10.1126/science.273.5277.974 · DOI · Paper page
  7. Baxter, 2001, Changes in the IGF-IGFBP axis in critical illness, Best Pract Res Clin Endocrinol Metab, 15, 421, 10.1053/beem.2001.0161 · DOI
  8. Van den Berghe, 2000, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness, J Clin Endocrinol Metab, 85, 183
  9. Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I, Clin Endocrinol (Oxf), 35, 47, 10.1111/j.1365-2265.1991.tb03495.x · DOI · Paper page
  10. Baxter, 1998, Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients, Growth Horm IGF Res, 8, 455, 10.1016/S1096-6374(98)80298-0 · DOI
  11. Hermansson, 1997, Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery, J Clin Endocrinol Metab, 82, 421
  12. Defalque, 1999, GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors, Am J Physiol, 276, E565
  13. Van den Berghe, 1997, The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion, J Clin Endocrinol Metab, 82, 590
  14. Van den Berghe, 1998, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues, J Clin Endocrinol Metab, 83, 309
  15. Van den Berghe, 1999, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness, J Clin Endocrinol Metab, 84, 1311
  16. Friesema, 2005, Thyroid hormone transporters, Biochem Soc Trans, 33, 228, 10.1042/BST0330228 · DOI
  17. Chopra, 1985, Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses, J Clin Endocrinol Metab, 60, 666, 10.1210/jcem-60-4-666 · DOI · Paper page
  18. Michalaki, 2001, Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery, J Clin Endocrinol Metab, 86, 4198
  19. Lim, 1993, Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids, J Clin Endocrinol Metab, 76, 1165
  20. Gardner, 1979, Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation, N Engl J Med, 300, 579, 10.1056/NEJM197903153001102 · DOI · Paper page
  21. Moshang, 1975, Low serum triiodothyronine in patients with anorexia nervosa, J Clin Endocrinol Metab, 40, 470, 10.1210/jcem-40-3-470 · DOI · Paper page
  22. Fivez, 2016, Early versus late parenteral nutrition in critically ill children, N Engl J Med, 374, 1111, 10.1056/NEJMoa1514762 · DOI · Paper page
  23. Hermans, 2013, Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial, Lancet Respir Med, 1, 621, 10.1016/S2213-2600(13)70183-8 · DOI · Paper page
  24. Gunst, 2013, Impact of early parenteral nutrition on metabolism and kidney injury, J Am Soc Nephrol, 24, 995, 10.1681/ASN.2012070732 · DOI
  25. Langouche, 2013, Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study, J Clin Endocrinol Metab, 98, 1006, 10.1210/jc.2012-2809 · DOI · Paper page
  26. Van den Berghe, 1997, Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues, Clin Endocrinol (Oxf), 47, 599, 10.1046/j.1365-2265.1997.3371118.x · DOI · Paper page
  27. Fliers, 1997, Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness, J Clin Endocrinol Metab, 82, 4032
  28. Bacci, 1982, The relationship between serum triiodothyronine and thyrotropin during systemic illness, J Clin Endocrinol Metab, 54, 1229, 10.1210/jcem-54-6-1229 · DOI · Paper page
  29. Damas, 1989, Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans, Crit Care Med, 17, 975, 10.1097/00003246-198910000-00001 · DOI · Paper page
  30. Faglia, 1973, Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects, Horm Metab Res, 5, 289, 10.1055/s-0028-1093930 · DOI · Paper page
  31. Van den Berghe, 1994, Dopamine and the sick euthyroid syndrome in critical illness, Clin Endocrinol (Oxf), 41, 731, 10.1111/j.1365-2265.1994.tb02787.x · DOI · Paper page
  32. Van den Berghe, 1994, Dopamine suppresses pituitary function in infants and children, Crit Care Med, 22, 1747, 10.1097/00003246-199422110-00008 · DOI
  33. Alkemade, 2006, Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary, Eur J Endocrinol, 154, 491, 10.1530/eje.1.02111 · DOI
  34. Langouche, 2013, Anterior pituitary morphology and hormone production during sustained critical illness in a rabbit model, Horm Metab Res, 45, 277
  35. Mebis, 2009, Expression of thyroid hormone transporters during critical illness, Eur J Endocrinol, 161, 243, 10.1530/EJE-09-0290 · DOI · Paper page
  36. Thijssen-Timmer, 2007, Thyroid hormone receptor isoform expression in livers of critically ill patients, Thyroid, 17, 105, 10.1089/thy.2006.0164 · DOI
  37. Van den Berghe, 2002, The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone, Clin Endocrinol (Oxf), 56, 655, 10.1046/j.1365-2265.2002.01255.x · DOI · Paper page
  38. Weekers, 2004, Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness, Endocrinology, 145, 205, 10.1210/en.2003-1005 · DOI
  39. Lebrethon, 1994, Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II, J Clin Invest, 93, 1828, 10.1172/JCI117168 · DOI
  40. Lehoux, 1989, Hormonal regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in the rat adrenal gland, J Steroid Biochem, 34, 379, 10.1016/0022-4731(89)90112-X · DOI
  41. Lehoux, 1998, The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo, Endocrinology, 139, 3913, 10.1210/endo.139.9.6196 · DOI
  42. Liu, 2000, Expression of low and high density lipoprotein receptor genes in human adrenals, Eur J Endocrinol, 142, 677, 10.1530/eje.0.1420677 · DOI
  43. Simpson, 1983, Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex, Can J Biochem Cell Biol, 61, 692, 10.1139/o83-088 · DOI · Paper page
  44. Miesfeld, 2001, Glucocorticoid action: biochemistry, 1647
  45. Burchard, 2001, A review of the adrenal cortex and severe inflammation: quest of the “eucorticoid” state, J Trauma, 51, 800, 10.1097/00005373-200110000-00033 · DOI
  46. Vermes, 1995, Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone, J Clin Endocrinol Metab, 80, 1238
  47. Marik, 2002, Adrenal insufficiency in the critically ill: a new look at an old problem, Chest, 122, 1784, 10.1378/chest.122.5.1784 · DOI · Paper page
  48. Pemberton, 1988, Hormone binding globulins undergo serpin conformational change in inflammation, Nature, 336, 257, 10.1038/336257a0 · DOI · Paper page
  49. Hammond, 1990, A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils, J Clin Endocrinol Metab, 71, 34, 10.1210/jcem-71-1-34 · DOI · Paper page
  50. Finlay, 1982, Serum cortisol levels in severely stressed patients, Lancet, 1, 1414, 10.1016/S0140-6736(82)92531-4 · DOI
  51. Rothwell, 1991, Cortisol response to corticotropin and survival in septic shock, Lancet, 337, 582, 10.1016/0140-6736(91)91641-7 · DOI · Paper page
  52. Span, 1992, Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients, Intensive Care Med, 18, 93, 10.1007/BF01705039 · DOI
  53. Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862 · DOI · Paper page
  54. Sam, 2004, Cortisol levels and mortality in severe sepsis, Clin Endocrinol (Oxf), 60, 29, 10.1111/j.1365-2265.2004.01923.x · DOI · Paper page
  55. Vermes, 2001, The hypothalamic-pituitary-adrenal response to critical illness, Best Pract Res Clin Endocrinol Metab, 15, 495, 10.1053/beem.2001.0166 · DOI
  56. Deutschman, 2013, Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis, Crit Care Med, 41, e368, 10.1097/CCM.0b013e31828e9843 · DOI
  57. Boonen, 2014, Impact of duration of critical illness on the adrenal glands of human intensive care patients, J Clin Endocrinol Metab, 99, 4214, 10.1210/jc.2014-2429 · DOI
  58. Karpac, 2008, Failure of adrenal corticosterone production in POMC-deficient mice results from lack of integrated effects of POMC peptides on multiple factors, Am J Physiol Endocrinol Metab, 295, E446, 10.1152/ajpendo.00762.2007 · DOI
  59. Barquist, 1997, Adrenal insufficiency in the surgical intensive care unit patient, J Trauma, 42, 27, 10.1097/00005373-199701000-00006 · DOI
  60. Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N Engl J Med, 358, 111, 10.1056/NEJMoa071366 · DOI · Paper page
  61. Mesotten, 2008, The altered adrenal axis and treatment with glucocorticoids during critical illness, Nat Clin Pract Endocrinol Metab, 4, 496, 10.1038/ncpendmet0921 · DOI
  62. van den Berghe, 2001, Intensive insulin therapy in critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Van den Berghe, G.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2016-12-01
Volume
194
Issue
11
Pages
1337-1348
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2508756596
Cited by
107
References
37
FWCI
7.22
Type
journal article
Language
en
Open access
green
Funders
  • Research Foundation Flanders (G041712N)
  • Methusalem Program of the Flemish Government (METH/14/06)
  • European Research Council (FP7/2013-2018)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. https://app.cochat.ai/papers/10.1164/rccm.201607-1516ci
The paper
Van den Berghe, G. (2016). On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201607-1516ci

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.